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Human Cytomegalovirus Infection of Langerhans-Type Dendritic Cells
Does Not Require the Presence of the gH/gL/UL128-131A Complex
and Is Blocked after Nuclear Deposition of Viral Genomes in
Immature Cells
Elvin J. Lauron,a Dong Yu,b* Anthony R. Fehr,b* Laura Hertela
‹Center for Immunobiology and Vaccine Development, Children’s Hospital Oakland Research Institute, Oakland, California, USAa; Department of Molecular Microbiology,
Washington University School of Medicine, St. Louis, Missouri, USAb
Human cytomegalovirus (CMV) enters its host via the oral and genital mucosae. Langerhans-type dendritic cells (LC) are the
most abundant innate immune cells at these sites, where they constitute a first line of defense against a variety of pathogens. We
previously showed that immature LC (iLC) are remarkably resistant to CMV infection, while mature LC (mLC) are more permis-
sive, particularly when exposed to clinical-strain-like strains of CMV, which display a pentameric complex consisting of the viral
glycoproteins gH, gL, UL128, UL130, and UL131A on their envelope. This complex was recently shown to be required for the
infection of immature monocyte-derived dendritic cells. We thus sought to establish if the presence of this complex is also neces-
sary for virion penetration of LC and if defects in entry might be the source of iLC resistance to CMV. Here we report that the
efficiency of LC infection is reduced, but not completely abolished, in the absence of the pentameric complex. While virion pene-
tration and nuclear deposition of viral genomes are not impaired in iLC, the transcription of the viral immediate early genes
UL122 and UL123 and of the delayed early gene UL50 is substantially lower than that in mLC. Together, these data show that the
UL128, UL130, and UL131A proteins are dispensable for CMV entry into LC and that progression of the viral cycle in iLC is re-
stricted at the step of viral gene expression.
Myeloid dendritic cells (DC) are the most potent inducers ofadaptive immune responses (1, 2) and are highly abundant
in skin and mucosae, where they provide a first line of defense
against invading pathogens while simultaneously acquiring anti-
gens for subsequent presentation to T and B lymphocytes (3, 4).
Tissue-resident myeloid DC are conventionally considered “im-
mature” on the basis of their large antigen uptake capacity but
relatively low T-cell stimulatory ability. Activation by danger sig-
nals such as contact with pathogens or inflammatory cytokines
can then trigger their maturation and migration to the draining
lymphnodes, where, asmatureDC, they can stimulate naiveT and
B cells to proliferate and differentiate into effector T cells and
antibody-producing plasma cells, respectively (5). Despite playing
a critical role in the regulation of immunity, DC and theirmyeloid
precursors can themselves become means of infection with and
persistence and dissemination of numerous pathogens, including
human cytomegalovirus (CMV) (6).
CMV is a ubiquitous herpesvirus that can cause severe disease
in immunocompromised individuals, such as solid organ and
bone marrow transplant recipients, AIDS patients, and newborns
(7, 8). The oral, nasal, and genital mucosae are natural routes of
CMV acquisition and spread to new hosts via urine and saliva
(7–9). Mucosal DC residing at these anatomical locations are
among the first cell types to encounter CMV during entry and can
modulate the outcome of infection by contributing to virus dis-
semination during their migration toward the draining lymph
nodes and by stimulating the onset of adaptive immune responses
against CMV. Not surprisingly, myeloid DC are major targets of
CMV’s immunoevasive strategies aimed at damping and delaying
the proper onset of antiviral immune responses until latency is
established in hematopoietic progenitor cells (6, 10, 11).
CMV reactivation from latency is also intrinsically linked to
the process of CD34 and CD14 cell differentiation into DC and
macrophages (12, 13), rendering tissue-resident DC an important
source of newly produced infectious virus (14–18). By reseeding
key tissues such as the salivary glands with reactivated virus, these
DC can effectively contribute to the horizontal transmission
of CMV.
Langerhans-type DC (LC) account for the totality of innate
immune cells residing in the epithelial layer of the oral mucosae,
while other types of myeloid DC, displaying surface markers sim-
ilar to dermal DC, reside in deeper layers, including the lamina
propria and submucosa (19–22). DC populations morphologi-
cally, immunohistochemically, and ultrastructurally identical to
LC can be differentiated in vitro from CD34 hematopoietic pro-
genitor cells (23–26), while a type of DC considered by some to be
analogous to dermal CD14 DC (25–27) and by others to be in-
flammatory cells distinct from resident, steady-state dermal DC
(28, 29) can be obtained frommonocytes (monocyte-derived DC
[MDDC]).
These two types ofDCdiffer substantially in their susceptibility
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to CMV infection in vitro. While immature LC (iLC) are remark-
ably resistant regardless of the virus strain (30), immatureMDDC
(iMDDC) are fully permissive, but exclusively to infection by clin-
ical-strain-like strains, which possess an extended tropism com-
pared to that of laboratory-adapted strains (31–36). Both attenu-
ated strain AD169varATCC and clinical-strain-like strain TB40/E
can initiate infection in mature LC (mLC), albeit with different
efficiencies (30), while the extent of permissiveness of mature
MDDC remains unclear (32, 33, 35, 36).
A pentameric complex that consists of the viral proteins gH,
gL, UL128, UL130, and UL131A and is displayed on the envelope
of endotheliotropic but not laboratory-adapted strains was re-
cently shown to be required for virion entry into monocytes and
endothelial and epithelial cells (37–40). Strains naturally lacking
the expression of a functional UL131 (e.g., AD169varATCC),
UL130 (e.g., TownevarRIT3), or UL128 (e.g., Merlin) protein, as
well as viruses engineered to carrymutations in these open reading
frames (ORFs) (41–43), failed to initiate infection in all three cell
types, indicating that each of these proteins is individually re-
quired for tropism (37, 38, 44). All three gene products were also
shown to be indispensable for direct infection of iMDDC and for
virion transfer from infected human umbilical vein endothelial
cells to iMDDC (37, 45).
We previously showed that mLC can be productively infected
with AD169varATCC, a strain containing the gH/gL/gO, but not
the gH/gL/UL128-131A, complex on its envelope (46, 47). We
thus asked whether the pentameric complex is actually required
for CMV infection of LC.We found that both iLC andmLC could
be readily accessed by all of the strains tested, irrespective of the
gH/gL complex combination present on their envelopes, suggest-
ing that the UL128-131A proteins are not essential for CMV entry
into LC.
Consistent with our previous findings (30), onset of produc-
tive infection in iLC remained extremely inefficient. To identify
the source of this resistance, the progress of infection in iLC was
compared to that in mLC. While no substantial difference was
observed in the proportion of penetrated virions or in the number
of viral genomes reaching the nucleus, the efficiency of UL122/
UL123 and UL50 ORF transcription was severely reduced in iLC,
leading to a nearly complete loss of expression of essential imme-
diate early protein 1 (IE1) and IE2.
Together, these data show that CMVentry into iLC andmLC is
not restricted to strains harboring the gH/gL/UL128-131A com-
plex on their envelopes and that infection progress in iLC is
blocked at the step of viral immediate early gene expression, with
negative consequences for the efficient progression of the viral
cycle.
MATERIALS AND METHODS
Cells. Human foreskin fibroblasts (HFF, a kind gift from E. S. Mocarski,
Emory University, Atlanta, GA) and ARPE-19 retinal pigment epithelial
cells (a gift from M. McVoy, Virginia Commonwealth University, Rich-
mond, VA) were propagated in Dulbecco’s modified Eagle medium sup-
plementedwith 10% fetal clone serum III (HyClone), 100U/ml penicillin,
100 g/ml streptomycin, 4 mM HEPES, and 1 mM sodium pyruvate
(Gibco, Life Technologies, Grand Island, NY). CD34 hematopoietic
progenitor cells were magnetically separated with the CD34 MicroBead
kit (Miltenyi Biotec, Auburn, CA) from mononuclear cells obtained by
Ficoll-Hypaque density gradient centrifugation of peripheral blood sam-
ples collected in the Department of Hematology, Pediatric Sickle Cell
Program and Apheresis Program, Children’s Hospital & Research Center
Oakland, Oakland, CA. iLC populations were obtained by culturing
CD34 cells at a density of 1 104 to 2.5 104 per well in 48-well tissue
culture plates with serum-free X-VIVO 15 medium (Lonza/BioWhit-
taker, Allendale,NJ) supplementedwith 1,500 IU/ml of granulocyte-mac-
rophage colony-stimulating factor (GM-CSF, Leukine [sargramostim];
Immunex, Seattle,WA), 2.5 ng/ml of tumor necrosis factor, 20 ng/ml of
stem cell factor, 100 ng/ml of Flt3 ligand, and 0.5 ng/ml of transforming
growth factor 1 (all purchased from Peprotech, Rocky Hill, NJ) for 10
days as previously described (30, 48, 49). mLC were subsequently ob-
tained by exposing iLC to X-VIVO 15 medium containing 10% fetal bo-
vine serum, 200 ng/ml of CD40 ligand (Immunex, Seattle, WA), 1,500
IU/ml of GM-CSF, and 250 ng/ml of lipopolysaccharide (Sigma-Aldrich,
St. Louis, MO) for 2 days.
Virus strains. AD169varATCC (50), originally purchased from the
American Type Culture Collection (ATCC), and TowneGFP-IE2, a green
fluorescent protein (GFP)-tagged derivative of TownevarRIT3 (51), were
gifts from E. S.Mocarski (Emory University, Atlanta, GA). TR-GFP, a gift
from D. Yu (Washington University, St. Louis, MO), was derived from
pTRgfp, a bacterial artificial chromosome (BAC) clone of the clinical iso-
late TR (52) carrying the BAC vector sequence juxtaposed to a loxP site in
place of the US2-5 region (53). In TR-GFP, the missing US2-5 region in
pTRgfp was repaired, a second loxP site was inserted to bracket the BAC
vector sequence for its excision during virus reconstitution, and a GFP
expression cassette was introduced for tracking of infection. This simian
virus 40 promoter-driven green fluorescent protein (GFP) expression cas-
sette was inserted into the intergenic region between US7 and US8 and in
the same transcriptional orientation as these two ORFs to minimize po-
tential interference with their expression. Reconstitution of the TR-GFP
virus, containing the full-length viral genome and expressing GFP, was
then done by electroporation ofMRC-5 cells with 5g of purified pTRgfp
BACDNA and with 1 g each of expression plasmids encoding pp71 and
the Cre recombinase to promote the excision of the BAC vector sequence.
The US17 deletion mutant virus TRsubUS17 was derived from pTRgfp by
replacing the 882-bp sequence encoding US17 with a 2.3-bp GalK/kana-
mycin cassette (A. Fehr and D. Yu, unpublished). BADrUL131-Y4 (39), a
gift from M. McVoy (Virginia Commonwealth University, Richmond,
VA), was derived from a variant of the AD169 BAC clone BADwt (54)
containing the GFP sequence, an internal ribosomal entry site, the puro-
mycin resistance gene in lieu of the UL21.5 ORF (55), and the wild-type
UL131A sequence from TR replacing the mutated original AD169 se-
quence (39). Escherichia coli bacteria harboring the BAC clones of CMV
strains TB40-BAC4 (56) and TB40-BAC4 UL128ccta82-86 were gifts
from C. Sinzger (University of Ulm, Ulm, Germany). UL128ccta82-86
was derived from TB40-BAC4 by replacing the nucleotide sequence en-
coding the charged amino acid cluster HSLTR of UL128 with the nucleo-
tide sequence encoding the neutrally charged amino acid stretch ASLTA,
yielding a mutant virus incapable of assembling the gH/gL/UL128-
UL131A complex (43). Live virus was reconstituted by transfection of
BAC DNA in HFF with the Polyfect Transfection reagent in accordance
with the manufacturer’s instructions (Qiagen). Transfected cells were
maintained with regular medium changes until a 100% cytopathic effect
was observed. The supernatant was then harvested and used as the inoc-
ulum for virus amplification. All strains were propagated on HFF and
purified by ultracentrifugation as previously described (30). Virus titers
were determined by plaque assay on HFF monolayers in 24-well tissue
culture plates. Six (TB40-BAC4), four (TB40-BAC4 UL128ccta82-86),
three (BADrUL131-Y4), four (AD169varATCC), four (Towne GFP-IE2),
four (TR-GFP), and three (TRsubUS17) different stocks of each virus
were used for the experiments described. The identity of each strain was
verified by PCR amplification of viral DNA extracted from virion prepa-
rations with primers mapping to the UL128-UL131A locus, followed by
bidirectional sequencing of the DNA.
Cell infection. HFF and ARPE-19 cells were plated at a density of
2 104/cm2 3 days before exposure to CMV at a multiplicity of infec-
tion (MOI) of 5 or 10 PFU/cell or to medium alone (mock). The virus
Lauron et al.
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inoculumwas left in contact with cells at 37°C in 5%CO2 until the time of
harvest or for only 4 h. In the latter experiments, after removal of the
inoculum, cells were washed twice, treated with citrate buffer (40 mM
citric acid, 10 mM KCl, 135 mM NaCl, pH 3) for 1 min (min) at room
temperature (RT) to inactivate residual bound virus (57), washed again
twice, and incubated in fresh medium until harvest. At the end of the
differentiation (iLC) or maturation (mLC) period, LC were harvested,
counted, resuspended in fresh differentiation or maturation medium
again, and exposed to CMV at an MOI of 10 or 100 PFU/cell. The virus
inoculumwas then left in contactwith the cells until the time of harvest. In
selected experiments, after removal of the inoculum, cells were washed
twice in medium prior to treatment with citrate buffer as described above
or with 1 mg/ml of proteinase K for 1 h at 4°C to proteolytically remove
cell surface virions (58–60). Cells were then washed again twice, pelleted,
and stored at 80°C for subsequent analyses or incubated in fresh me-
dium until harvest.
IFA. For immunofluorescence staining analyses (IFA), HFF and
ARPE-19 cells were plated on 12-mm-diameter glass coverslips, while iLC
andmLCwere harvested and deposited on glass slides by centrifugation at
800 rpm for 3min at RTwith a Cytospin 4 (Thermo Shandon). Cells were
fixed in 1% formaldehyde for 30min at RT, permeabilized in 0.5%Triton
X-100 for 20 min on ice, and treated with blocking buffer (40% goat
serum–40% fetal bovine serum in phosphate-buffered saline [PBS]) for
30 min at RT. Samples were then incubated with mouse monoclonal an-
tibodies against the viral IE1/IE2 proteins (1:500, MAb810; Chemicon,
Temecula, CA) or against pp150 (1:400, originally from W. Britt, Bir-
mingham, AL) for 1 h at RT in a humidified chamber, washed in blocking
buffer, and incubated with Alexa Fluor 594-conjugated goat anti-mouse
antibodies (1:500; Molecular Probes, Eugene, OR) for 1 h at RT. For dual
staining, cells were incubated in blocking buffer containingmousemono-
clonal anti-pp150 antibodies and rabbit polyclonal anti-lamin B antibod-
ies (1:50; Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h at RT,
washed in blocking buffer, and incubated with Alexa Fluor 594-conju-
gated goat anti-mouse and Alexa Fluor 488-conjugated goat anti-rabbit
antibodies (1:500;Molecular Probes, Eugene,OR) for another hour at RT.
Nuclei were labeled with Hoechst 33342 (0.2 mg/ml; Molecular Probes,
Eugene, OR) for 3 min at RT. Slides were mounted in 90% glycerol–10%
PBS containing 2.5 g/liter of 1,4-diazabicyclo-(2,2,2)-octane (DABCO;
Alfa Aesar, Pelham, NH) prior to viewing on a Nikon Eclipse E600 fluo-
rescencemicroscope equippedwith iVision-Mac imaging software or on a
Zeiss LSM710 confocal inverted microscope equipped with Zeiss ZEN
image-processing software. Processing and three-dimensional recon-
structions of confocal z-stack images were conducted with the Bitplane
Imaris Suite package of ScientificVolume Imaging (Hilversum,TheNeth-
erlands) and the Surpass Surfaces and the Surpass Section visualization
tools.
FISH assays. Probes consisted of a mixture of 10 pSC-B plasmids
(StrataClone Ultra Blunt PCR Cloning kit; Agilent Technologies, Santa
Clara, CA) containing the following DNA fragments from the genome of
CMV strain FIX-BAC (AC146907): nucleotides (nt) 69050 to 77680
(8,630 nt in length), 77680 to 86900 (9,220 nt), 86900 to 94700 (7,800 nt),
94400 to 102800 (8,400 nt), 136500 to 143600 (7,100 nt), 143300 to
150200 (6,900 nt), 149800 to 156800 (7,000 nt), 166400 to 173500 (7,100
nt), 173350 to 178000 (4,650 nt), and 178000 to 184700 (6,700 nt). Two
micrograms of a pSC-B plasmidmixturewas labeled by nick translation in
the presence of 0.004 U of DNase I (New England BioLabs), 10 U of DNA
polymerase I (New England BioLabs), and 10 M ChromaTide Alexa
Fluor 594-5-dUTP (Molecular Probes, Eugene, OR) at 15°C for 75 min.
Labeled probes were then cleaned with the QIAquick Gel Extraction kit
(Qiagen, Valencia, CA) and resuspended in fluorescence in situ hybrid-
ization (FISH) buffer (2 SSC [1 SSC is 0.15 M NaCl plus 0.015 M
sodium citrate], 50% deionized formamide, 20% dextran sulfate).
iLC and mLC were harvested and deposited on glass slides by centrif-
ugation as described above. Slides were then fixed in cold 95% etha-
nol–5% glacial acetic acid for 5 min at20°C, rinsed once in 100% eth-
anol, and air dried prior to prehybridization in FISH buffer for 30 min at
37°C in a humidified slide hybridization chamber. After the addition of 5
to 10 l of labeled probe, slides were incubated at 95°C for 2 min to
denature DNA. Hybridization was then carried out in a moist hybridiza-
tion chamber overnight (18 to 20 h) at 37°C. Slides were subsequently
washed with 2 SSC twice for 5 min at 60°C and once for 5 min at RT,
dried, and stained with Hoechst 33342 (0.2 mg/ml) for 3 min at RT. After
three washes in PBS, slides were mounted in ProLong Gold Antifade Re-
agent (Molecular Probes, Life Technologies, Grand Island, NY) and
viewed on a Zeiss LSM710 confocal inverted microscope equipped with
Zeiss ZEN image-processing software.
Real-time quantitative genomic PCR and reverse transcription-
PCR. Genomic DNA was extracted from infected HFF, ARPE-19 cells,
iLC, and mLC with the QIAamp DNA minikit (Qiagen, Valencia, CA).
mRNAwas obtained from infected iLC andmLCwith theMACSmRNA
isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany), treated with
DNase (DNA-free kit; Invitrogen, Life Technologies, Grand Island, NY)
to remove any contaminating genomicDNA, and reverse transcribedwith
SuperScript II reverse transcriptase (Invitrogen, Life Technologies, Grand
Island, NY). Real-time quantitative PCRs were performed in triplicate
with iTaq SYBR green Supermix with ROX (Bio-Rad, Hercules, CA) and
anABI7900 thermocycler (Applied Biosystems, Carlsbad, CA)with prim-
ers hybridizing to exon 2 of the viral UL122 and UL123 ORFs (forward
primer, 5=-GGCCGAAGAATCTCTCAAAA-3=; reverse primer, 5=-TCGT
TGCAATCCTCGGTCA-3=), to the viral UL50 ORF (forward primer, 5=-
AGAATTCATGGAGATGAACAAGGTT-3=; reverse primer, 5=-ACTCG
AGTCAGTCGCGGTGTGC-3=), or to the cellular albumin gene (forward
primer, 5=-GCTGTCATCTCTTGTGGGCTGT-3=; reverse primer, 5=-AA
ACTCATGGGAGCTGCTGGTT-3=). The following cycling parameters
were used: 95°C for 2 min to activate the iTaq polymerase, followed by 40
cycles of template denaturation at 95°C for 15 s, primer annealing at 51°C
(UL122/123 andUL50) or 57°C (albumin) for 30 s, and product extension
at 72°C for 30 s. Absolute quantifications of viral genome, viral transcript,
and cellular genome amounts were obtained by using a standard curve
made by serial dilutions of plasmid pON303 (61), a kind gift from E. S.
Mocarski (Emory University, Atlanta, GA), of plasmid LNCX UL50-HA
(62), and of a plasmid we constructed (pTOPO-albumin) that contains a
portion of the albumin gene corresponding to nt 16,000 to 16,500. The
number of viral genome copies per cell was then calculated as follows:
number of viral genome copies per cell 	 number of viral DNA copies/
(number of albumin DNA copies/2) (63).
RESULTS
The UL128-131A proteins are not required for CMV infection
of iLC and mLC. We previously showed that CMV strain
AD169varATCC can infect mLC, despite lacking the gH/gL/
UL128-131A complex. This suggested that the UL128-131A pro-
teins might not be tropism determinants for this type of DC. To
test this idea, iLC and mLC populations differentiated from the
CD34 progenitor cells of multiple donors were exposed to CMV
strains displaying different gH/gL complex combinations on their
envelopes and the efficiency of infection onset was assessed by
determining the percentage of cells expressing the IE1/IE2 pro-
teins at 48 hpi. Infections of ARPE-19 epithelial cells were con-
ducted in parallel for comparison. The strains used in this study
and their gH/gL envelope complexes are listed in Table 1. Briefly,
virions from the UL128mut, AD169, and Towne strains display
only the gH/gL/gO trimer (43, 46, 47, 64), while TR, BAC4, and
BADr particles harbor both the gH/gL/gO and gH/gL/UL128-
131A entry complexes (39, 40, 65).
To directly compare the infectious properties of each strain for
each cell type in an unbiasedway, the following experimental con-
ditions were implemented. First, all virus stocks were generated
and titers were determined in HFF, in order to standardize the
CMV Infection of Langerhans Dendritic Cells
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effects of the producer cell type on the tropism and entrymodes of
the viral progeny (66, 67). HFF were chosen on account of their
abilities to support the growth of the AD169, Towne, and
UL128mut strains and to produce viral particles with a tropism
broader than that of those released by endothelial cells (66).
Second, at least three different stocks of each strainwere tested,
in order to assess the robustness of each strain’s behavior and to
minimize the effect of adventitious mutations potentially arising
during CMV amplification in vitro. As the growth of clinical-
strain-like strains on HFF is associated with the relatively rapid
appearance of mutations in the ORFs encoding the UL128,
UL130, and UL131A proteins (68), the nucleotide sequence of the
UL128-131A genomic locus of each strain was verified by PCR
amplification and sequencing of virion DNA.
Third, infectionswere carried out in the absence of adsorption-
enhancing treatments such as exposure to polyethylene glycol or
centrifugation to test the natural capacity of each strain to access
cells (59, 66, 69–72). Finally, viruses were left in contact with cells
until the time of harvest, in order to avoid the centrifugation step
required to remove the virus inoculum from LC cultures growing
in suspension.
Consistent with expectations (39), BAC4 and BADr expressed
the IE1/IE2 proteins in the majority of ARPE-19 cells, while
AD169, Towne, and UL128mut initiated infection in less than
0.5% of the cells (Table 2). In contrast, and contrary to published
data obtainedwith the TR strain (59), TR-GFP failed to infect cells
with high efficiency, despite carrying an intact UL128-131A locus.
To verify this finding, we tested the infectivity of a different TR-
GFP-derived virus, TRsubUS17, which lacks the ORF encoding
US17 (D. Yu, unpublished data). Although the function ofUS17 is
not known, this protein is not expected to be directly involved in
CMV tropism. Similar to TR-GFP, TRsubUS17 also inefficiently
infected ARPE-19 cells (Table 2), indicating that the observed
phenotype was not due to changes occurring during amplification
of the TR-GFP strain in our experiments and suggesting that other
viral determinants of tropism for epithelial cells are likely to exist
in addition to the UL128-131A proteins. Mutations in the ORF(s)
encoding this as-yet-unidentified factor(s) and arising within the
TR-GFP genome would be maintained in the derived virus
TRsubUS17, producing identical phenotypes with respect to these
strains’ tropism for epithelial cells.
Consistent with our previous findings (30), mLC were overall
more permissive to infection than iLC were (Fig. 1A and B). Sim-
ilar to ARPE-19 cells, BAC4 and BADr were more efficient than
UL128mut and AD169 at initiating infection in mLC, while TR-
GFP yielded the lowest percentage of IE1/IE2 cells (Fig. 1B). As
the extent of infection was highly dependent on the donor of the
progenitor cells used to differentiate LC, the infectivities of strains
possessing or not possessing the gH/gL/UL128-131A complex
were compared in side-by-side infections of mLC derived from
the same donors (Fig. 1C andD). The percentage of infectedmLC
observed after exposure to BAC4 was virtually identical to that
detected after exposure toUL128mut in cultures derived from3 of
11 donors and 2- to 5-fold higher in the remaining cultures (Fig.
1C), with an overall median BAC4/UL128mut ratio of 2.3
 1.5.
Similarly, the ratio of the percentages of BADr- and AD169-in-
fected cells was1 for mLC derived from two of nine donors and
ranged between 1.4 and 2.6 for the rest of the cultures (Fig. 1D),
with a median value of 1.8
 0.5.
Both TR-GFP and TRsubUS17 did not effectively enter mLC,
yielding percentages of IE1/IE2 cells 3.5-fold (TR-GFP) and












AD169varATCC AD169 None Plaque-purified derivative of ATCC stocks Yes No 46, 47, 64
Towne GFP-IE2 Towne None GFP-IE2-expressing derivative of
TownevarRIT3
Yes No 64
TR-GFP TR-GFP None GFP-expressing derivative of TR-BAC
containing a full-length genome
Yes Yes 65
TRsubUS17 TRsubUS17 None TR-GFP derivative carrying the GalK/
kanamycin cassette in lieu of the US17
ORF
Yes Yes 65
TB40-BAC4 BAC4 US2-US6 Highly endotheliotropic BAC clone of
TB40/E
Yes Yes 40, 65, 66
TB40-BAC4
UL128ccta82-86
UL128mut US2-US6 BAC clone of TB40/E with the HSLTR
amino acid sequence of UL128 mutated
to ASLTA
Yes No 43
BADrUL131-Y4 BADr UL21.5 BAC clone of AD169 with the UL21.5
ORF replaced with the GFP and
kanamycin resistance genes and the
original UL131A ORF replaced with the
UL131A ORF from strain TR
Yes Yes 38
TABLE 2 Percentages of IE1/IE2 ARPE-19 cells after infection at an
MOI of 10
CMV strain






BAC4 48 (5.4) 3 3
UL128mut 0.02 (0.1) 2 5
BADr 100 (0) 2 6
AD169 0.24 (0.4) 3 18
Towne 0.12 (0.4) 3 5
TR 1.81 (1.3) 4 8
TRsubUS17 2.53 (2) 3 5
Lauron et al.
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2-fold (TRsubUS17) lower than those observed after infection
with BAC4 (six donors). Similar to the situation in ARPE-19 cells,
TRsubUS17 was slightly more efficient than TR-GFP at initiating
infection of mLC, with a median TRsubUS17/TR-GFP ratio of
1.7
 0.3 (nine donors).
Aside from being more resistant to infection, iLC responses to
each strain were largely similar to those of mLC, with BADr being
better than AD169, TRsubUS17 being better than TR-GFP, and
BAC4 being better than both TR-GFP and TRsubUS17 at initiat-
ing infection (Fig. 1A). In contrast to mLC, however, exposure to
BAC4 or UL128mut yielded virtually identical proportions of in-
fected cells, with a median BAC4/UL128 ratio of 0.9 
 1.6 in
parallel infections of cultures derived from six donors.
Thus, absence of the gH/gL/UL128-131A complex from the
virion envelope effectively abolished viral entry into ARPE-19
cells and had essentially no impact on iLC infection but reduced
the efficiency of mLC infection by approximately 2-fold. These
data therefore indicate that, in contrast to epithelial cells, the pres-
ence of the UL128, UL130, and UL131A proteins is irrelevant for
viral entry into iLC and is advantageous but not essential for entry
into mLC. The low infectivity of TR-GFP for iLC, mLC, and
ARPE-19 cells, moreover, implies that other viral proteins besides
UL128, UL130, and UL131A may have a role in mediating CMV
tropism for epithelial cells and LC. Finally, the small but consis-
tent difference between the efficiencies of infection of TR-GFP
and TRsubUS17 may hint at a potential role for US17 in restrain-
ing infection onset in LC and ARPE-19 cells, identifying this pro-
tein as a potential temperance factor (73).
CMV virion entry is not blocked in iLC. The fact that no viral
strain with the ability to initiate productive infection in iLC has
been found hints at the presence of host defense mechanisms that
cannot be overcome by any viral protein encoded by the strains
tested so far.
To identify the step in the viral cycle that is blocked in iLC, the
progress of viral particles was tracked by staining infected iLC and
mLC for pp150, a tegument phosphoprotein that remains
strongly associated with capsids during entry and has been used as
a capsid marker by us and others (60, 74, 75). Cytospin prepara-
tions of iLC and mLC exposed to BAC4 at an MOI of 10 PFU/cell
and harvested at 0.25, 1, 5, 20, and 30 hpi were fixed and perme-
abilized prior to the addition of anti-pp150 antibodies. The effi-
cacy of permeabilization was verified by staining cells with anti-
bodies against the nuclear envelope protein lamin B. While no
signal corresponding to pp150 was observed in mock-infected,
permeabilized iLC (Fig. 2A to C) or mLC (not shown), viral par-
ticles were clearly visible as bright dots (Fig. 2D and G) in infected
samples. At each of the times tested, the overall abundances of
viral particles appeared to be similar in infected iLC and mLC
(Fig. 2, compare D and G; data not shown). To precisely quantify
these data, the number of particles per cell observed in at least 200
cells from at least five different fields per time point was deter-






























































































FIG 1 Efficiency of iLC and mLC infection by CMV strains carrying different entry complexes on their envelopes. (A and B) Percentages of IE1/IE2 cells after
infection of iLC (A) or mLC (B) with different CMV strains at an MOI of 10 PFU/cell. Each symbol represents a separate donor of CD34 progenitor cells used
to differentiate iLC and mLC populations. A horizontal bars marks the median value of each group. (C and D) Percentages of IE1/IE2 cells obtained after
side-by-side infections of mLC derived from 11 (C) and 9 (D) different donors.
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ratio was calculated (Fig. 2J). At 15 min postinfection, iLC and
mLC populations appeared to harbor similar numbers of parti-
cles/cell, with mean values of 4
 1 for iLC and 4.6
 1 for mLC
(Fig. 2J, 0.25 hpi), indicating that the efficiencies of virion attach-
ment and initial entry into the two cell types were highly compa-
rable, albeit lower than expected for an MOI of 10 PFU/cell. At
both 1 and 5 hpi, mLC contained approximately 40% more par-
ticles than iLC did, but by 20 hpi, these differences had waned and
both cell types again contained similar number of particles. No
disparity was observed at 30 hpi either, although the total amount
of virions was greatly reduced from the beginning of infection,
potentially because of capsid disassembly after viral genome de-
livery into the nucleus. Thus, while mLC appeared to contain
slightly larger amounts of virions than iLC did at early times, sim-
ilar number of particles were found in each cell type at later time
points, suggesting that virion entry into iLC is not dramatically
hindered.
As these assays did not allow us to distinguish between virions
attached to the cell surface and those that had already penetrated
the cell, we next treated infected cells with citrate buffer, which
was expected to inactivate and detach nonpenetrating virions the
cell from its surface (57, 76–78), or with proteinase K, which has
been reported to proteolytically remove residual extracellular par-
ticles (58–60). Real-time quantitative PCR was then used instead
of IFA to determine the number of viral genomes per cell under
each condition. iLC and mLC populations derived from the pro-
genitor cells of four different donors were exposed to BAC4 at an
MOI of 10 PFU/cell for 15min, 1 h, or 4 h. At each time point, cells
were collected, washed, and stored (untreated) or washed and
treated with citrate buffer for 1 min at room temperature or with
proteinase K for 1 h at 4°C. After additional washes, cells were
pelleted and subjected to real-time quantitative PCRwith primers
hybridizing to the viral UL122/123 ORF (79) or to the cellular
albumin gene (63) and the number of viral genomes/cell was cal-
culated.
At each of the time points tested, iLC contained slightly but
consistently larger amounts of viral DNA than mLC did (Fig. 3A,
white bars), with iLC/mLC ratios ranging from 2
 1.5 at 15 min
postinfection to 3.8
 1 at 4 h postinfection (Fig. 3B, white bars).
These values are higher than those obtained by IFA (Fig. 2J), likely
because of the superior precision of the quantification method
used (real-time PCR instead of manual counting), the testing of
cell populations derived from four different CD34 cell donors
instead of one, and the tracking of viral genomes instead of viral
FIG 2 CMV particle density on iLC and mLC at early times postinfection. (A
to I) iLC and mLC populations differentiated from the progenitor cells of a
representative donor were left untreated (mock) or exposed to BAC4 at an
MOI of 10 PFU/cell. Cells were harvested at 0.25, 1, 5, 20, and 30 hpi, washed
once in medium, and centrifuged on glass slides. Samples were then fixed,
permeabilized, and stained for pp150 (left panels) and lamin B (middle pan-
els). Nuclei were counterstained with Hoechst 33345 (right panels). (J) Me-
dian number of viral particles permLC or per iLC observed in 280 to 1,170 iLC
found in 5 to 15 different microscopy fields and in 210 to 410 mLC found in 6
to 11 fields. Standard deviations and iLC/mLC ratios are shown. The dashed




















































FIG 3 Viral genome contents of iLC and mLC at early times postinfection. iLC and mLC populations differentiated from the progenitor cells of four different
CD34 cell donors were exposed to BAC4 at an MOI of 10 PFU/cell. At 0.25, 1, and 4 hpi, cells were collected, washed, and stored (untreated); washed and
exposed to citrate buffer to inactivate nonpenetrating viral particles; or washed and treated with proteinase K to remove extracellular virions. Real-time
quantitative PCRwas thenused to determine the number (n.) of viral genome copies per cell at each time postinfection (A) and to derive the ratio of the calculated
number of viral genome copies present in iLC to the number present in mLC (B).
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capsids. Treatment of infected cells with citrate buffer did not
change the viral genome content of iLC and had only modest
effects (25, 10, and 17% decrease from untreated samples at 0.25,
1, and 4 h, respectively) on mLC (Fig. 3A, gray bars), suggesting
that, contrary to what was reported for other cell types (57, 76–
78), exposure to a low pH did not completely remove nonpen-
etrating virions from infected LC. Identical results were obtained
after iLC treatment with proteinase K, while enzymatic digestion
of mLC resulted in the removal of 55 to 64% of the bound virions
(Fig. 3A, black bars), consistent withwhatwas previously reported
for monocytes, fibroblasts, and epithelial cells (58, 59). Viral par-
ticle attachment and internalization may thus occur more effi-
ciently in iLC than in mLC. Already at 15 min postinfection, vir-
tually all of the virions bound to iLC are protected from
proteolysis, presumably on account of their localization within
the cell’s interior. In contrast, only about 36 to 44%of the attached
particles are internalized bymLC at each of the time points tested,
suggesting that entry intomLCmay be slower or less effective than
entry into iLC. Because of these differences, the intracellular con-
tent of viral particles was consistently higher (6.5-fold
 2-fold to
9-fold
 0.7-fold) in iLC than in mLC at each time postinfection
(Fig. 3B, black bars).
Together, these data indicate that virion entry into iLC occurs
with similar or better efficiencies than virion entry intomLC, sug-
gesting that defects in binding and penetration are not the main
source of iLC resistance to infection.
Viral genome losses are similar in iLC and mLC. To deter-
mine if any difference might exist in the way viral particles are
processes by each LC type after penetration, the fate of viral ge-
nomes over time was tracked in HFF and ARPE-19 cells, used as
reference, and in iLC and mLC infected with BAC4, UL128mut,
BADr, andAD169 at anMOI of 10 PFU/cell. Cells were exposed to
each strain for 4 h before being washed withmedium, treated with
citrate buffer to inactivate residual nonpenetrating virus, and
washed extensively again. Real-time quantitative PCR was then
used to determine the number of viral genomes present in each
cell population at 4, 8, 24, and 48 hpi and to calculate the propor-
tion of genomes remaining at each time point relative to that at 4
hpi (Fig. 4), when the entry of noninternalized virions was halted
by low-pH treatment. The calculated average number of viral ge-
nomes per cell found in each population at 4 hpi averaged 2.6 

1.8 in iLC, 1.3
 1.1 in mLC, 2.7
 2 in ARPE-19 cells, and 3.1

3 in HFF. Again, at this early time postinfection, iLC appeared to
holdmore viral genomes thanmLC did, while the viral DNA con-
tents of HFF and ARPE-19 cells were almost identical.
As expected, all of the strains could efficiently infect HFF. The
content of viral DNA remained largely the same in these cells from
4 to 24 hpi, until the onset of viral replication caused it to increase
at 48 hpi (Fig. 4A, C, E, and G, dark gray bars). The same profile
was observed inARPE-19 cells infectedwith BAC4 andBADr (Fig.
4A and E, light gray bars), while genomes from UL128mut and
AD169 were gradually lost over time with no amplification at 48
hpi (Fig. 4C and G, light gray bars). The detection of UL128mut
and AD169 genomes in ARPE-19 cell samples at the early time of
8 hpi clearly indicates that at least virion binding, if not also pen-
etration, can occur in these cells in the absence of the gH/gL/
UL128-131A pentamer. The sharp drop in viral DNA amounts
observed later on, however, reveals that the entry route used by
these virions may not be viable, failing to lead to successful ge-
nome replication.
A gradual decline in the cellular content of viral genomes was
observed in both LC types, irrespective of the strain used for in-
fection (Fig. 4B, D, F, and H). This decrease was slightly more
pronounced in mLC than in iLC, which retained approximately
50% more input (4 hpi) viral DNA than mLC did at 48 hpi, on
average (Fig. 4J). As expected, because of the delayed CMV repli-
cation kinetics in mLC compared to those in HFF and ARPE-19
cells (30), no boost in viral DNA copy numbers was detected in
mLC at 48 hpi. The fact that expression of the IE1/IE2 proteins
could be detected at this same time point, however, indicates that
the viral replication cycle had successfully started in these cells.
In summary, no substantial difference was detected in the cel-
lular content of viral genomes after infection of LC with strains
carrying functional or dysfunctional UL128-131A complexes, as
shown by the relatively small standard deviations in Fig. 4J com-
pared to those of ARPE-19 cells in Fig. 4I. This suggests that LC
may process incoming virions from different strains in similar
ways, leading to comparable proportions of infected cells (Fig. 1)
and supporting the notion that the UL128, UL130, and UL131A
proteins are not essential for LC infection. The extent of viral
genome loss was larger in both LC types than in HFF or ARPE-19
cells (when exposed to BAC4 or BADr), but while enhanced ge-
nome lossmay contribute toARPE-19 cells’ resistance to infection
by certain strains (Fig. 4C andG), no obvious correlation could be
found between the extent of genome retention in LC and the pro-
portion of IE1/IE2 cells. Despite still containing 41%
 10% of
the input viral DNA at 48 hpi (Fig. 4J), only 3%
 2% of the iLC
(average of four donors) were IE1/IE2 (Fig. 4J); in contrast,mLC
retained merely 20%
 11% of the initial viral genomes, and yet,
14% 
 11% of them expressed the IE1/IE2 proteins. These data
suggest that increased genome loss due to the degradation of viral
DNA, the ejection of penetrated particles, or other unknown
mechanisms may contribute to the decreased permissiveness of
mLC compared to that of HFF or ARPE-19 cells but are not likely
to be the prime source of iLC resistance.
Nuclear deposition of CMVgenomes is occurring in iLC.We
subsequently sought to establish if viral genomes did successfully
reach the nuclei of iLC or if, instead, they remained trapped in the
cell cytoplasm. High-magnification images of iLC harvested at 4
hpi with BAC4 and stained for pp150 showed the presence of
numerous virions in close proximity to the nucleus (Fig. 5A).
Confocal microscopy imaging further revealed the existence of
what appeared to be points of contact between some viral particles
and the outer surface of the nuclei of both iLC andmLC (Fig. 5B to
E, arrows), suggesting that capsids could successfully dock to the
nuclear envelope in both cell types. To determine if viral genomes
were subsequently deposited into the nucleus, cytospin prepara-
tions of LC infected with BAC4 and harvested at 24 hpi were
subjected to FISH labeling with probes hybridizing to the viral
genome. Bright dots corresponding to viral DNA could be de-
tected within the nuclei of both iLC andmLC (Fig. 5D to G), with
no apparent difference between the two cell types with respect to
genome localization or the number of genomes per nucleus. In
fact, iLC and mLC samples could not be distinguished in blinded
analyses of FISH slides, suggesting that nuclear deposition of viral
genomes was occurring with similar efficiencies in both LC types.
The abundance of UL122/UL123 andUL50 transcripts is sig-
nificantly lower in iLC. Finally, we sought to determine if tran-
scription of the UL122/123 andUL50ORFs was similarly efficient
in iLC and mLC. The UL122/123 ORF is expressed with immedi-
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ate early kinetics and encodes the IE1 and IE2 proteins essential for
infection onset (80–82), while the UL50 ORF is expressed with
early kinetics and encodes the nuclear egress complex component
UL50 (83–85). Real-time, quantitative reverse transcription-PCR
was used to determine the numbers of UL122/123 andUL50 tran-
script copies present in each cell type at 24, 48, and 72 h postex-
posure to AD169, BADr, BAC4, or UL128mut and to calculate the
ratio of the number of cDNA copies of each gene present in the
mLC to the number of copies in the iLC of each donor (Fig. 6).
Although the UL122/123ORFwas expressed in both cell types,
mLC consistently contained more transcript copies than iLC at
each time point. Already at 24 hpi, the number of UL122/123
mRNA copies in mLC was 6 times (AD169 and BAC4), 8 times
(UL128mut), and 12 times (BADr) greater than that in iLC
8 hpi 24 hpi 48 hpi






















































































































































FIG4 Viral genome contents ofHFF, ARPE-19 cells, iLC, andmLCat later times postinfection. Cells were exposed to BAC4,UL128mut, BADr, orAD169 virions
at anMOI of 10 PFU/cell for 4 h, washed inmedium to remove the inoculum, and treated with citrate buffer to prevent any further virion penetration. A quarter
of the cells were then harvested immediately (4 hpi), while the rest were plated and harvested at 8, 24, and 48 hpi. Real-time quantitative PCR was used to
determine the number of viral genome copies per cell at each time point and to calculate the percentage of genomes remaining at 8, 24, and 48 hpi relative to that
at 4 hpi (% 4 hpi). (A, C, E, and G) Genomes remaining in ARPE-19 cells and HFF from one representative experiment, with the 48-hpi values shown on a log10
scale. (B, D, F, and H)Mean percentages of genomes remaining in iLC andmLC derived from four different CD34 cell donors with standard deviations. (I and
J)Mean percentages of genomes remaining in each population after infection with BAC4, UL128mut, BADr, and AD169 with standard deviations. Values above
the columns at 48 hpi are the percentages of IE1/IE2 cells obtained in IFA analyses of each cell type at 48 hpi.
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(Fig. 6A, white bars). These differences further increased for two
donors at 48 hpi (43- and 40-fold in AD169-infected cells, 26- and
25-fold in BADr-infected cells) while remaining close to 5-fold for
the other two. An increase was also detected after infection with
BAC4 (14-fold) and UL128mut (10-fold) (Fig. 6A, light gray
bars). Finally, the ratios remained high at 72 hpi, with median
values of 10-fold (AD169) and 24-fold (BADr), while decreasing
back to 6-fold and 4-fold after infection with BAC4 and
UL128mut, respectively (Fig. 6A, dark gray bars).
Similar results were obtained for UL50 in LC populations de-
rived from the CD34 cells of two donors. Consistent with data
from infected fibroblasts (83), UL50 was expressed at 24 hpi in
both LC types, albeit at different levels (medianmLC/iLC ratios of
11 in AD169, 12 in BADr, 10 in BAC4, and 7 in UL128mut infec-
tions, Fig. 6B, white bars). While the number of UL50 mRNA
copies in mLC remained at least 5-fold higher than that in iLC at
each time point after infection with AD169 or BADr, differences
were somewhat lower at 72 h after infection with BAC4 and
UL128mut (Fig. 6B, dark gray bars). Considering that at both 24
and 48 h after infection with each strain, iLC contain more viral
genomes than mLC (Fig. 4B, D, F, and H) but substantially less
UL122/123 andUL50mRNA copies (Fig. 6), transcription of viral
genes in iLC appears to be highly restricted. Together, these data
identify viral gene transcription as the first severely impaired step
in the regular progression of the viral cycle in iLC.
FIG 5 Localization of viral particles and genomes within iLC and mLC. Cells
were exposed to BAC4 at anMOI of 10 PFU/cell, harvested at 4 hpi (A to E) or
24 hpi (F to M), and processed by IFA with anti-pp150 antibodies (A to E) or
by FISH with probes hybridizing to the viral genome (F to M). (A) Superim-
position of light and fluorescence images of an infected iLC. The signal from
pp150 viral particles appears as sharp black dots. N, nucleus. Original mag-
nification,60. (B to E)Confocalmicroscopy images of infected iLC andmLC
stained with anti-pp150 antibodies (red signal) and with Hoechst 33345 (light
blue signal). Merged z-stack images were processed with the Imaris Surpass
Surfaces visualization tool to create an artificial solid-object representation of
specified gray value ranges in the data set. Images are shown frontwise in panels
B and C and rotated leftwise and tilted at an45° angle in panels D and E. The
total z-stack thickness of the iLC sample was 2.45 m, while the mLC sample
measured 3.51 m. Arrows point at viral particles that appear to be in close
contact with the nuclear envelope.Originalmagnification,63. Bars, 5m. (F
to M) Confocal microscopy images of infected iLC and mLC stained with a
ChromaTide Alexa Fluor 594-labeled probe hybridizing to multiple different
regions of the viral genome (red signal) and with Hoechst 33345 (light blue
signal). The merged images in panels F and J were processed with the Surpass
Section visualization tool to display the frontal (x, y, main square) and orthog-
onal (x, z, bottom rectangle) and (y, z, right rectangle) views of the z stack,
while the images in panels G to I and K to M were processed with the Surpass
Surfaces visualization tool and show nuclei frontwise in panels G and K, tilted
at an30° angle in panels H and L, and tilted at an90° angle in panels I and




























































FIG 6 Ratios of UL122/123 and UL50 transcript amounts present in infected
iLC andmLC.mRNA extracted from cells exposed to AD169, BADr, BAC4, or
UL128mut at an MOI of 10 PFU/cell and harvested at 24, 48, and 72 hpi was
DNase treated and reverse transcribed.Quantitative real-timePCRassayswere
then used to quantify the number (n.) of UL122/123 and UL50 cDNA copies
present in the equivalent of 1 102 iLC or mLC per reaction and to calculate
the ratio of the copy amounts found in mLC to those detected in iLC differen-
tiated from the progenitor cells of three or four (UL122/123, A) and two
(UL50, B) different CD34 progenitor cell donors. Each floating vertical bar
extends from the minimum to the maximum ratio obtained for the iLC and
mLC from different donors at each time point, while a horizontal bar marks
the median value of each group.
CMV Infection of Langerhans Dendritic Cells
January 2014 Volume 88 Number 1 jvi.asm.org 411
 o
n
 January 28, 2014 by W







Efficient CMV penetration of specific cell types requires fusion
of the virion envelope with cellular membranes in a process
controlled by both viral and cellular factors. Capsid release into
the cytoplasm can indeed occur at the periphery of the cell or
from intracellular vesicles, depending on the complement of
glycoprotein complexes displayed on the virion surface and on
the cell type.
The gH/gL/UL128-131A complexwas shown to promote entry
by endocytosis and to be essential for the infection of epithelial
cells, endothelial cells, monocytes, and iMDDC (38, 40, 45, 59, 67,
86). Exposure to strains carrying only the gH/gL/gO complex was
not followed by viral gene expression in these cells, implying that
endocytosis is likely the predominant, if not the only, entry path-
way conducive to productive infection onset.
Consistent with this, we found that viral DNA maintenance
and replication, as well as IE1/IE2 protein expression, in ARPE-19
epithelial cells occurred only after infection with strains possess-
ing the pentameric complex and presumably entering by endocy-
tosis (Table 2 and Fig. 4).
In contrast to the infection of epithelial cells, that of HFF does
not require expression of the UL128, UL130, and UL131A pro-
teins but depends on the presence of the gH/gL/gO complex to
support fusion of the viral envelope with the plasma membrane
(46, 72, 87, 88). In our assays, penetration of HFF by virions from
strains possessing or lacking the gH/gL/UL128-131A complex
progressed equally well and led to the onset of productive infec-
tions (Fig. 4A, C, E, andG), suggesting that both entrymodesmay
be allowed to occur in this cell type. Alternatively, virions of
strains harboring both complexes on their envelope, such as BAC4
andBADr,may selectively use the trimeric complex to accessHFF.
While the intracellular release of naked capsids at the cell periph-
ery is considered to be the main entry route of CMV into these
cells (88), incoming virions were also detected within phagolyso-
some-like vacuoles in electron microscopic images of infected
cells (89), suggesting that endocytosis of viral particles can also
take place in HFF.
Here we show that the pentameric complex is not required for
infection of iLC and mLC, although in its presence, the efficiency
ofmLC infectionwas increased by about 2-fold (Fig. 1). Similar to
the situation in HFF, strains containing both complexes or just
gH/gL/gO were equally able to bind to and likely enter both types
of LC, but their genomicDNAwas subsequently lost (Fig. 4B,D, F,
and H), in a fashion comparable to that of UL128mut and AD169
in ARPE-19 cells (Fig. 4C and G). In contrast to the latter, how-
ever, the rate and extent of viral genome loss were similar for all
strains (Fig. 4J) and were not accompanied by a complete absence
of IE1/IE2 gene expression in mLC (Fig. 4J and 1B). It is thus
possible that, akin to HFF, both endocytosis and fusion with the
plasma membrane are viable routes of entry into iLC and mLC
andmay be used interchangeably by virions possessing both com-
plexes.When only the gH/gL/gO complex is present, particlesmay
still use both pathways to access cells, as suggested by the lack of
difference between the intracellular contents of viral DNA of dif-
ferent strains. Because the endocytic pathway is impracticable in
the absence of the pentameric complex, a portion of these virions
may fail to reach the nucleus, leading to a reduction in the per-
centage of IE1/IE2mLC.
Our finding that mLC are consistently more permissive to in-
fection than iLC are (Fig. 1) (30) is in stark contrast to the situa-
tion with MDDC, whereby immature cells, and not their mature
counterparts, are the most susceptible to CMV infection (33–36).
Despite being related and sharing many of the features and func-
tions typical of antigen-presenting cells, LC and MDDC respond
to CMV in opposite ways, reflecting the heterogeneity and func-
tional specialization of different DC populations. If these differ-
ences observed in vitro are also mirrored in vivo, then dermal DC
and epidermal LC are likely to play dramatically different roles in
the development of CMV pathogenesis and in the generation of
antiviral immune responses, a concept thatmay be relevant for the
development of live-attenuated vaccines intended for delivery via
mucosal surfaces.
None of the CMV strains tested so far has the ability to initiate
productive infections in iLC. This strongly supports the existence
of some iLC-specific defensemechanism that cannot be overcome
by any viral countermeasure. Intriguingly, while entry is the target
of multiple cellular antiviral strategies restricting infection in dif-
ferent cell types, CMV penetration of iLC is not blocked. Quite to
the contrary, data from our particle neutralization/detachment
experiments indicate that virion internalization is more efficient
in iLC than in mLC (Fig. 3A), leading to higher, instead of lower,
intracellular contents of virions at early times postinfection
(Fig. 3B).
This finding may not be that surprising in view of the well-
known superior antigen-capturing abilities of iLC, compared to
mLC (25, 90). While all three antigen internalization pathways,
namely, macropinocytosis, endocytosis, and phagocytosis, are
fully operational in iLC, two (macropinocytosis and phagocyto-
sis) are downregulated during maturation (91, 92), leaving endo-
cytosis as the predominant means of extracellular material acqui-
sition by mLC. While our data suggest that CMV entry into mLC
may occur independently of vesicle-mediated transport pathways
(Fig. 1), the loss of two prominent entry routes followingmatura-
tion may negatively impact the efficiency of CMV penetration of
these cells, at least in the case of pentamer-containing strains such
as BAC4.
Subsequent to entry, no major differences were detected be-
tween iLC andmLC in the kinetics of viral genome loss (Fig. 4J) or
in the number of viral genomes reaching the nucleus, arguing
against enhanced virion degradation or inefficient nuclear depo-
sition of viral genomes as the main cause of iLC resistance to
infection. In contrast, the abundance of UL122/123 and UL50
ORFs transcripts was considerably lower in iLC than in mLC at
each of the times tested (Fig. 6), pointing at viral gene transcrip-
tion as the first severely restricted step in the regular progression of
the viral cycle.
The most intriguing question now is how viral gene transcrip-
tion is blocked in iLC. It is, of course, possible for iLC to express
higher levels of specific transcriptional repressors, whose binding
to the major immediate early promoter (MIEP) is followed by the
severe inhibition of UL122/123 expression. Conversely, mLCmay
contain higher levels of transcriptional activators, whose positive
activity on theMIEPmay promote the onset of lytic infection. The
resistance to CMV infection of undifferentiated human mono-
cytic THP-1 cells, for instance, was found to be partially due to the
presence of theMBF1 andMRF transcriptional repressors in large
amounts (93, 94). UponTHP-1 differentiation intomacrophages,
the abundance of both factors was substantially reduced, with a
concomitant increase in MIEP activity. This allowed the expres-
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sion of the IE1/IE2 proteins and initiation of the viral replication
cycle to occur (93, 94). Epigenetically acting proteins such as his-
tone acetyltransferases, histone deacetylases, and histone methyl-
transferases may also be potential players. In latently infected
CD34 progenitor cells, the transcriptionally inactive UL122/123
promoter was indeed found to be associated with deacetylated H4
histones and with the transcriptional repressor heterochromatin
protein 1 (HP1), while inmLC derived from latently infected pro-
genitors and harboring reactivating virus, the now active UL122/
123 promoter was associated with acetylated H4 histones and had
lost HP1 binding (15–17). Interestingly, and similar to our find-
ings with directly infected iLC, no expression of the viral UL122/
123ORFs was detected in iLC differentiated from latently infected
CD34 cells, indicating that maturation is crucial for both infec-
tion onset and viral reactivation to occur. Thus, although CMV
reactivation in the CD34-LC model was proposed to be “differ-
entiation dependent” (95), we believe that it may be more tightly
linked to the process of maturation (i.e., “maturation depen-
dent”). Interestingly, while differentiation and maturation of la-
tently infected CD34 progenitors into mLC trigger viral reacti-
vation (15, 16), maturation of directly infected iLC has not yet
been reported to yield infectious virus. This suggests that the
mechanismsmediating silencing of theMIEP in iLC derived from
latently infected progenitors may be different from those acting
after direct infection of these cells.
Finally, mLC susceptibility to direct infection, as well as the
establishment of viral latency inCD34 cells, was also proposed to
be regulated by the activity of nuclear domain 10 (ND10) bodies
(96), whose negative effects onMIEP transcription (97–99) can be
partially reversed by the nuclear delivery of the viral tegument
protein pp71 (100–105). Although no evidence was provided by
Saffert et al. as to the actual presence of viral genomes within the
ND10 bodies of infected CD34 cells ormLC (96), pp71 appeared
to reach the nucleus in at least a few infected mLC. If incoming
viral genomes are indeed sequestered within the ND10 bodies of
iLC and if pp71 is subsequently prevented from reaching the nu-
cleus, then silencing of theMIEPmay remain in effect, preventing
the expression of the UL122/123 ORFs in these cells. On the other
hand, depletion of theND10 component and the strong transcrip-
tional repressor hDaxx from nonpermissive human teratocarci-
noma T2 cells did not render them susceptible to infection (106),
and neither was their loss of resistance (triggered by exposure to
vasoactive intestinal peptide) accompanied by hDaxx degradation
(107), suggesting that the role played by hDaxx and pp71 in con-
trolling CMV infection onset may be cell dependent and that they
may not be active in iLC.
Altogether, we postulate that iLC resistance to infection is
highly unlikely to depend on the activity of single cellular proteins.
Instead, multiple host defense effectors may cooperate in generat-
ing an unfavorable environment for viral gene transcription. Con-
versely, mLC susceptibility to CMV infection and reactivation
may depend on the assembly of an intranuclear milieu conducive
to MIEP activation and be characterized by the presence of se-
lected transcription factors, the absence of others, and the occur-
rence of specific epigenetic modifications of the viral and cellular
genomes (95, 108). The relative contributions of some of these
elements to the regulation of LC susceptibility to infection are
under investigation.
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